Resources from the same session
Welcome and Introduction
Presenter: Javier Cortés
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Antibody-Drug Conjugates for HR-Positive Breast Cancer: Where Are We Today?
Presenter: Peter Fasching
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Next-Generation Antibody-Drug Conjugates in Practice: A Case-Based Discussion
Presenter: Sara Hurvitz
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
New Antibody-Drug Conjugates on the Horizon
Presenter: Peter Schmid
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Audience Q&A
Presenter: All Speakers
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast